Friday, December 12, 2025 | 03:58 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

STATSGURU: Here's how the world's coronavirus vaccine map looks like

Most vaccines are not yet available in plenty, and are costly, too

AstraZeneca wasn't the obvious choice to partner up with Oxford when scientists there started developing a coronavirus shot. Photographer: Mikael Sjoberg/Bloomberg
premium

Abhishek Waghmare
The three leading Covid-19 vaccines are making their way towards the first line of beneficiaries. While the Pfizer and Moderna vaccines are being administered in tens of countries, the Oxford-AstraZeneca (Ox-As) jab was recently approved by India. All of them, to varying extent, have proven to be effective enough for usage. But the Ox-As vaccine fares the best in terms of commitment towards a more equitable distribution, chart 1 shows.




Most vaccines are not yet available in plenty, and are costly, too. So much so that rich countries have taken the lead in purchase deals, and reported